ヘリコバクター・パイロリ感染症と多発性硬化症の患者における臨床的特徴の評価:白症と共存する症例シリーズ
Maryam Aghaei1, Shahrzad Aghaei2, Zabihollah Shahmoradi3
1Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Journal of the National Medical Association
|February 20, 2026
まとめ
ヘリコバクター・ピロリ菌感染症は,特に多発性硬化症 (MS) と白症の患者において,多発性自己免疫症候群 (MAS) に関する役割を果たす可能性があります. 根絶されたH. pyloriは,これらの患者で潜在的な臨床改善を示しました.
科学分野:
- 免疫学 免疫学とは
- 胃腸内科 胃腸内科
- 神経学 神経学とは
背景:
- 多発性自己免疫症候群 (MAS) は,少なくとも3つの自己免疫疾患を含む.
- MASの正確な原因は不明ですが,遺伝的,環境的,感染症的要因が関与しています.
- ヘリコバクター・パイロリ (H. pylori) は,自己免疫病理学に寄与する潜在的な要因である.
研究 の 目的:
- 多発性硬化症 (MS) の患者と併存する白症の人口統計学的および臨床的特徴を記述する.
- MS患者におけるH. pylori感染と白の関連性を調査する.
- これらの患者の臨床改善に対するH. pylori根絶の効果を評価する.
主な方法:
- ウィチリゴが確認された8人の女性MS患者を含むケース・シリーズ研究.
- 人口統計データと臨床データは,アンケートと医療記録を通じて収集されます.
- H. pyloriの感染は,ELISAと便の抗原検査を用いて評価され,陽性症例に根絶療法が投与されました.
主要な成果:
- MSと白の平均発症年齢は,それぞれ23.12 ± 5.27年と26.75 ± 4.97歳でした.
- H. pylori感染は,患者の25%で検出されました.
- H. pylori 根絶療法後のアクティブな白症は観察されなかった.
結論:
- H. pylori感染とMAS患者における白の病理生理学との間に潜在的な関連性がある.
- H. pyloriの根絶治療は,白症の補助治療として役立つ可能性があります.
- このアプローチは,MSと白症を含む,MASの患者に潜在的に利益をもたらす可能性があります.
関連する概念動画
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
667
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
667
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.5K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.5K
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
969
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
969
01:28Peptic Ulcer Disease II: Pathophysiology
2.3K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.3K
01:30Peptic Ulcer Disease I: Introduction
917
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
917
01:23Gastritis III: Clinical Manifestations and Management
1.4K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.4K